CLINICAL_TRIALS
trial_result
· 2021-09-28
Clinical Trial Update: CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms [Phase 2, Phase 3]
Summary
Clinical trial update for CANnabiDiol in mild to moderate COVID-19 patients across Phase 2 and Phase 3.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Sao Paulo | Conditions: SARS-CoV2 | Phase 2, Phase 3 | Status: UNKNOWN